Cargando…

Nomograms based on SUVmax of (18)F-FDG PET/CT and clinical parameters for predicting progression-free and overall survival in patients with newly diagnosed extranodal natural killer/T-cell lymphoma

BACKGROUND: The prognostic value of (18)F-FDG PET/CT in extranodal natural killer/T-cell lymphoma (ENKTL) is not well established. We aimed to develop nomograms for individualized estimates of progression-free survival (PFS) and overall survival (OS) in patients with ENKTL using (18)F-FDG PET/CT par...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hongyan, Shao, Guozhu, Zhang, Yajing, Chen, Xiaomin, Du, Chengcheng, Wang, Kun, Gao, Zairong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796613/
https://www.ncbi.nlm.nih.gov/pubmed/33419476
http://dx.doi.org/10.1186/s40644-020-00379-y
_version_ 1783634721191755776
author Li, Hongyan
Shao, Guozhu
Zhang, Yajing
Chen, Xiaomin
Du, Chengcheng
Wang, Kun
Gao, Zairong
author_facet Li, Hongyan
Shao, Guozhu
Zhang, Yajing
Chen, Xiaomin
Du, Chengcheng
Wang, Kun
Gao, Zairong
author_sort Li, Hongyan
collection PubMed
description BACKGROUND: The prognostic value of (18)F-FDG PET/CT in extranodal natural killer/T-cell lymphoma (ENKTL) is not well established. We aimed to develop nomograms for individualized estimates of progression-free survival (PFS) and overall survival (OS) in patients with ENKTL using (18)F-FDG PET/CT parameters and clinical parameters. METHODS: A total of 171 patients with newly diagnosed ENKTL undergoing (18)F-FDG PET/CT scanning were retrospectively analyzed. Nomograms were constructed according to multivariate Cox proportional hazards regression. The predictive and discriminatory capacities of the nomograms were then measured using the concordance index (C-index), calibration plots, and Kaplan-Meier curves. The C-index, the area under receiver operating characteristic (ROC) curve (AUC), and decision curve analysis (DCA) were used to contrast the predictive and discriminatory capacities of the nomograms against with the International Prognostic Index (IPI) and Korean Prognostic Index (KPI). RESULTS: Multivariate analysis demonstrated that pretreatment SUVmax≥9.5, disease stage II and III-IV, elevated lactate dehydrogenase (LDH), and elevated β2-microglobulin (β2-MG) had the strongest association with unfavorable PFS and OS. In addition, hemoglobin (Hb) < 120 g/L had a tendency to be associated with PFS. Both nomogram models incorporated SUVmax, Ann Arbor stage, LDH, and β2-MG. The PFS nomogram also included Hb. The nomograms showed good prediction accuracies, with the C-indexes for PFS and OS were 0.729 and 0.736, respectively. The calibration plots for 3-year and 5-year PFS/OS reported good consistency between predicted and observed probabilities for survival time. The PFS and OS were significantly different according to tertiles of nomogram scores (p < 0.001). The C-index and AUCs of the nomograms were higher than that of IPI and KPI. Moreover, DCA showed that the predictive accuracy of the nomograms for PFS and OS were both higher than that of IPI and KPI. CONCLUSIONS: This study established nomograms that incorporate pretreatment SUVmax and clinical parameters, which could be effective tools for individualized prognostication of both PFS and OS in patients with newly diagnosed ENKTL.
format Online
Article
Text
id pubmed-7796613
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-77966132021-01-11 Nomograms based on SUVmax of (18)F-FDG PET/CT and clinical parameters for predicting progression-free and overall survival in patients with newly diagnosed extranodal natural killer/T-cell lymphoma Li, Hongyan Shao, Guozhu Zhang, Yajing Chen, Xiaomin Du, Chengcheng Wang, Kun Gao, Zairong Cancer Imaging Research Article BACKGROUND: The prognostic value of (18)F-FDG PET/CT in extranodal natural killer/T-cell lymphoma (ENKTL) is not well established. We aimed to develop nomograms for individualized estimates of progression-free survival (PFS) and overall survival (OS) in patients with ENKTL using (18)F-FDG PET/CT parameters and clinical parameters. METHODS: A total of 171 patients with newly diagnosed ENKTL undergoing (18)F-FDG PET/CT scanning were retrospectively analyzed. Nomograms were constructed according to multivariate Cox proportional hazards regression. The predictive and discriminatory capacities of the nomograms were then measured using the concordance index (C-index), calibration plots, and Kaplan-Meier curves. The C-index, the area under receiver operating characteristic (ROC) curve (AUC), and decision curve analysis (DCA) were used to contrast the predictive and discriminatory capacities of the nomograms against with the International Prognostic Index (IPI) and Korean Prognostic Index (KPI). RESULTS: Multivariate analysis demonstrated that pretreatment SUVmax≥9.5, disease stage II and III-IV, elevated lactate dehydrogenase (LDH), and elevated β2-microglobulin (β2-MG) had the strongest association with unfavorable PFS and OS. In addition, hemoglobin (Hb) < 120 g/L had a tendency to be associated with PFS. Both nomogram models incorporated SUVmax, Ann Arbor stage, LDH, and β2-MG. The PFS nomogram also included Hb. The nomograms showed good prediction accuracies, with the C-indexes for PFS and OS were 0.729 and 0.736, respectively. The calibration plots for 3-year and 5-year PFS/OS reported good consistency between predicted and observed probabilities for survival time. The PFS and OS were significantly different according to tertiles of nomogram scores (p < 0.001). The C-index and AUCs of the nomograms were higher than that of IPI and KPI. Moreover, DCA showed that the predictive accuracy of the nomograms for PFS and OS were both higher than that of IPI and KPI. CONCLUSIONS: This study established nomograms that incorporate pretreatment SUVmax and clinical parameters, which could be effective tools for individualized prognostication of both PFS and OS in patients with newly diagnosed ENKTL. BioMed Central 2021-01-08 /pmc/articles/PMC7796613/ /pubmed/33419476 http://dx.doi.org/10.1186/s40644-020-00379-y Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Li, Hongyan
Shao, Guozhu
Zhang, Yajing
Chen, Xiaomin
Du, Chengcheng
Wang, Kun
Gao, Zairong
Nomograms based on SUVmax of (18)F-FDG PET/CT and clinical parameters for predicting progression-free and overall survival in patients with newly diagnosed extranodal natural killer/T-cell lymphoma
title Nomograms based on SUVmax of (18)F-FDG PET/CT and clinical parameters for predicting progression-free and overall survival in patients with newly diagnosed extranodal natural killer/T-cell lymphoma
title_full Nomograms based on SUVmax of (18)F-FDG PET/CT and clinical parameters for predicting progression-free and overall survival in patients with newly diagnosed extranodal natural killer/T-cell lymphoma
title_fullStr Nomograms based on SUVmax of (18)F-FDG PET/CT and clinical parameters for predicting progression-free and overall survival in patients with newly diagnosed extranodal natural killer/T-cell lymphoma
title_full_unstemmed Nomograms based on SUVmax of (18)F-FDG PET/CT and clinical parameters for predicting progression-free and overall survival in patients with newly diagnosed extranodal natural killer/T-cell lymphoma
title_short Nomograms based on SUVmax of (18)F-FDG PET/CT and clinical parameters for predicting progression-free and overall survival in patients with newly diagnosed extranodal natural killer/T-cell lymphoma
title_sort nomograms based on suvmax of (18)f-fdg pet/ct and clinical parameters for predicting progression-free and overall survival in patients with newly diagnosed extranodal natural killer/t-cell lymphoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796613/
https://www.ncbi.nlm.nih.gov/pubmed/33419476
http://dx.doi.org/10.1186/s40644-020-00379-y
work_keys_str_mv AT lihongyan nomogramsbasedonsuvmaxof18ffdgpetctandclinicalparametersforpredictingprogressionfreeandoverallsurvivalinpatientswithnewlydiagnosedextranodalnaturalkillertcelllymphoma
AT shaoguozhu nomogramsbasedonsuvmaxof18ffdgpetctandclinicalparametersforpredictingprogressionfreeandoverallsurvivalinpatientswithnewlydiagnosedextranodalnaturalkillertcelllymphoma
AT zhangyajing nomogramsbasedonsuvmaxof18ffdgpetctandclinicalparametersforpredictingprogressionfreeandoverallsurvivalinpatientswithnewlydiagnosedextranodalnaturalkillertcelllymphoma
AT chenxiaomin nomogramsbasedonsuvmaxof18ffdgpetctandclinicalparametersforpredictingprogressionfreeandoverallsurvivalinpatientswithnewlydiagnosedextranodalnaturalkillertcelllymphoma
AT duchengcheng nomogramsbasedonsuvmaxof18ffdgpetctandclinicalparametersforpredictingprogressionfreeandoverallsurvivalinpatientswithnewlydiagnosedextranodalnaturalkillertcelllymphoma
AT wangkun nomogramsbasedonsuvmaxof18ffdgpetctandclinicalparametersforpredictingprogressionfreeandoverallsurvivalinpatientswithnewlydiagnosedextranodalnaturalkillertcelllymphoma
AT gaozairong nomogramsbasedonsuvmaxof18ffdgpetctandclinicalparametersforpredictingprogressionfreeandoverallsurvivalinpatientswithnewlydiagnosedextranodalnaturalkillertcelllymphoma